269 related articles for article (PubMed ID: 33749726)
1. Salvage NAD+ biosynthetic pathway enzymes moonlight as molecular chaperones to protect against proteotoxicity.
Pinkerton M; Ruetenik A; Bazylianska V; Nyvltova E; Barrientos A
Hum Mol Genet; 2021 May; 30(8):672-686. PubMed ID: 33749726
[TBL] [Abstract][Full Text] [Related]
2. NAD+ salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded/oligomerized proteins.
Ocampo A; Liu J; Barrientos A
Hum Mol Genet; 2013 May; 22(9):1699-708. PubMed ID: 23335597
[TBL] [Abstract][Full Text] [Related]
3. N-terminal protein acetylation by NatB modulates the levels of Nmnats, the NAD
Croft T; Venkatakrishnan P; James Theoga Raj C; Groth B; Cater T; Salemi MR; Phinney B; Lin SJ
J Biol Chem; 2020 May; 295(21):7362-7375. PubMed ID: 32299909
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
Reis SD; Pinho BR; Oliveira JMA
Mol Neurobiol; 2017 Oct; 54(8):5829-5854. PubMed ID: 27660272
[TBL] [Abstract][Full Text] [Related]
5. A functional link between NAD
Croft T; James Theoga Raj C; Salemi M; Phinney BS; Lin SJ
J Biol Chem; 2018 Feb; 293(8):2927-2938. PubMed ID: 29317496
[TBL] [Abstract][Full Text] [Related]
6. YCL047C/POF1 is a novel nicotinamide mononucleotide adenylyltransferase (NMNAT) in Saccharomyces cerevisiae.
Kato M; Lin SJ
J Biol Chem; 2014 May; 289(22):15577-87. PubMed ID: 24759102
[TBL] [Abstract][Full Text] [Related]
7. NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration.
Zhai RG; Zhang F; Hiesinger PR; Cao Y; Haueter CM; Bellen HJ
Nature; 2008 Apr; 452(7189):887-91. PubMed ID: 18344983
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1.
Galka D; Ali TT; Bast A; Niederleithinger M; Gerhardt E; Motosugi R; Sakata E; Knop M; Outeiro TF; Popova B; Braus GH
Aging Cell; 2024 May; 23(5):e14128. PubMed ID: 38415292
[TBL] [Abstract][Full Text] [Related]
9. The mouse nicotinamide mononucleotide adenylyltransferase chaperones diverse pathological amyloid client proteins.
Huang C; Lu J; Ma X; Qiang J; Wang C; Liu C; Fang Y; Zhang Y; Jiang L; Li D; Zhang S
J Biol Chem; 2022 May; 298(5):101912. PubMed ID: 35398355
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
Parsons RB; Kocinaj A; Ruiz Pulido G; Prendergast SA; Parsons AE; Facey PD; Hirth F
Hum Mol Genet; 2022 Aug; 31(17):2918-2933. PubMed ID: 35397003
[TBL] [Abstract][Full Text] [Related]
11. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies.
Ali YO; Allen HM; Yu L; Li-Kroeger D; Bakhshizadehmahmoudi D; Hatcher A; McCabe C; Xu J; Bjorklund N; Taglialatela G; Bennett DA; De Jager PL; Shulman JM; Bellen HJ; Lu HC
PLoS Biol; 2016 Jun; 14(6):e1002472. PubMed ID: 27254664
[TBL] [Abstract][Full Text] [Related]
12. The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions.
Fortunato C; Mazzola F; Raffaelli N
IUBMB Life; 2022 Jul; 74(7):562-572. PubMed ID: 34866305
[TBL] [Abstract][Full Text] [Related]
13. Isonicotinamide enhances Sir2 protein-mediated silencing and longevity in yeast by raising intracellular NAD+ concentration.
McClure JM; Wierman MB; Maqani N; Smith JS
J Biol Chem; 2012 Jun; 287(25):20957-66. PubMed ID: 22539348
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel human nicotinamide mononucleotide adenylyltransferase.
Raffaelli N; Sorci L; Amici A; Emanuelli M; Mazzola F; Magni G
Biochem Biophys Res Commun; 2002 Oct; 297(4):835-40. PubMed ID: 12359228
[TBL] [Abstract][Full Text] [Related]
15. Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters.
Zhang T; Berrocal JG; Frizzell KM; Gamble MJ; DuMond ME; Krishnakumar R; Yang T; Sauve AA; Kraus WL
J Biol Chem; 2009 Jul; 284(30):20408-17. PubMed ID: 19478080
[TBL] [Abstract][Full Text] [Related]
16. Proteostasis of Huntingtin in Health and Disease.
Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
[TBL] [Abstract][Full Text] [Related]
17. The ribosome-bound quality control complex: from aberrant peptide clearance to proteostasis maintenance.
Defenouillère Q; Fromont-Racine M
Curr Genet; 2017 Dec; 63(6):997-1005. PubMed ID: 28528489
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional negative feedback regulation of proteostasis through the Dis3 ribonuclease and its disruption by polyQ-expanded Huntingtin.
Kong KE; Hung TF; Man PM; Wong TN; Cheng T; Jin DY
Nucleic Acids Res; 2019 Nov; 47(19):10040-10058. PubMed ID: 31428776
[TBL] [Abstract][Full Text] [Related]
19. Synthesizing and salvaging NAD: lessons learned from Chlamydomonas reinhardtii.
Lin H; Kwan AL; Dutcher SK
PLoS Genet; 2010 Sep; 6(9):e1001105. PubMed ID: 20838591
[TBL] [Abstract][Full Text] [Related]
20. Suppression of protein aggregation by chaperone modification of high molecular weight complexes.
Labbadia J; Novoselov SS; Bett JS; Weiss A; Paganetti P; Bates GP; Cheetham ME
Brain; 2012 Apr; 135(Pt 4):1180-96. PubMed ID: 22396390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
